23 related articles for article (PubMed ID: 36272333)
1. 4-nitroquinoline 1-oxide-induced oral epithelial lesions exhibit time- and stage-dependent changes in the tumor immune microenvironment.
Sellæg K; Schwienbacher R; Kranz M; Aamodt AE; Wirsing AM; Berge G; Hadler-Olsen E; Magnussen SN
Front Oncol; 2024; 14():1343839. PubMed ID: 38812785
[TBL] [Abstract][Full Text] [Related]
2. Immune checkpoint ligands expressed on mature high endothelial venules predict poor prognosis of NSCLC: have a relationship with CD8
Luo J; Shi X; Liu Y; Wang J; Wang H; Yang X; Sun Q; Hui Z; Wei F; Ren X; Zhao H
Front Immunol; 2024; 15():1302761. PubMed ID: 38390332
[TBL] [Abstract][Full Text] [Related]
3. Integrative analysis of tertiary lymphoid structures and immune microenvironment in patients with esophageal carcinoma.
Yao Y; Xuan H; Wang J; Gong L; Gao W
Tumori; 2023 Oct; 109(5):466-480. PubMed ID: 37249074
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of tumor-infiltrating immune cells and PD-L1 expression in esophageal squamous cell carcinoma.
Jiang Y; Lo AWI; Wong A; Chen W; Wang Y; Lin L; Xu J
Oncotarget; 2017 May; 8(18):30175-30189. PubMed ID: 28404915
[TBL] [Abstract][Full Text] [Related]
5. Presence of high-endothelial venules correlates with a favorable immune microenvironment in oral squamous cell carcinoma.
Wirsing AM; Ervik IK; Seppola M; Uhlin-Hansen L; Steigen SE; Hadler-Olsen E
Mod Pathol; 2018 Jun; 31(6):910-922. PubMed ID: 29416107
[TBL] [Abstract][Full Text] [Related]
6. PLEK2 and IFI6, representing mesenchymal and immune-suppressive microenvironment, predicts resistance to neoadjuvant immunotherapy in esophageal squamous cell carcinoma.
Liu J; Chen H; Qiao G; Zhang JT; Zhang S; Zhu C; Chen Y; Tang J; Li W; Wang S; Tian H; Chen Z; Ma D; Tian J; Wu YL
Cancer Immunol Immunother; 2023 Apr; 72(4):881-893. PubMed ID: 36121452
[TBL] [Abstract][Full Text] [Related]
7. High endothelial venules are present in pharyngeal and laryngeal carcinomas and they are associated with better prognosis.
Karpathiou G; Dumollard JM; Gavid M; Casteillo F; Vieville M; Prades JM; Froudarakis M; Peoc'h M
Pathol Res Pract; 2021 Apr; 220():153392. PubMed ID: 33647862
[TBL] [Abstract][Full Text] [Related]
8. High endothelial venules associated with better prognosis in esophageal squamous cell carcinoma.
Li H; Tang L; Han X; Zhong L; Gao W; Chen Y; Huang J; Wen Z
Ann Diagn Pathol; 2022 Dec; 61():152051. PubMed ID: 36272333
[TBL] [Abstract][Full Text] [Related]
9. High endothelial venules in cancer: Regulation, function, and therapeutic implication.
Vella G; Hua Y; Bergers G
Cancer Cell; 2023 Mar; 41(3):527-545. PubMed ID: 36827979
[TBL] [Abstract][Full Text] [Related]
10. Cancer stem cells in esophageal squamous cell carcinoma.
Sun G; Yang Y; Liu J; Gao Z; Xu T; Chai J; Xu J; Fan Z; Xiao T; Jia Q; Li M
Pathol Res Pract; 2022 Sep; 237():154043. PubMed ID: 35926434
[TBL] [Abstract][Full Text] [Related]
11. Tertiary Lymphoid Structures: A Potential Biomarker for Anti-Cancer Therapy.
Zou J; Zhang Y; Zeng Y; Peng Y; Liu J; Xiao C; Wu F
Cancers (Basel); 2022 Dec; 14(23):. PubMed ID: 36497450
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
